drugset / Trial / NCT07415135
Safety and Efficacy of PSMA-Targeted Fluorescent Contrast Agent DGPR1008 for Intraoperative Imaging in Robot-Assisted Radical Prostatectomy
Non-randomizedSequentialOpen-labelTreatment
Summary
This study is a single-center, single-arm, open-label exploratory study to evaluate the safety and efficacy of fluorescent imaging combined with a robotic surgical control system for robot-assisted radical prostatectomy.
Timeline
- Start
- 2026-03-01
- Primary completion
- 2026-06-30
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DGPR1008 | Diagnostic / imaging agent | 0.02 mg/kg | — |
| Subject | DGPR1008 | Diagnostic / imaging agent | 0.04 mg/kg | — |
| Subject | DGPR1008 | Diagnostic / imaging agent | 0.06 mg/kg | — |